Phathom Pharmaceuticals

PHAT

NASDAQHealth Care

Income Statement

Total Revenue$55.25M

Gross Profit$47.28M

Operating Income$-277.47M

EBITDA$-261.52M

EBIT$-262.32M

Pre-tax Income$-221.25M

Net Income$-334.33M

Cash Equivalent$310.47M

Total Debt$495.75M

Book Value$-205.76M

Book Value Per Share-3.36

Return on Equity (ROE)-199.28%

Return on Assets (ROA)-88.37%

Return on Invested Capital (ROI)-88.87%

Net Profit Margin-605.09%

Current Ratio4.20

Quick Ratio3.92

Long-Term Debt / Equity1.24